Zacks1d agobullish
Halozyme's Q1 Earnings & Revenues Beat Estimates, Stock UpHALO beats Q1 earnings estimates as royalty revenues from partner drugs and strong product sales lift revenues by 42% year over year.
News
High-signal headlines only — macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
311last 24h
1815last 7d
322🟢 bullish (7d)
187🔴 bearish (7d)
129publishers
Zacks1d agobullish
Bayer Q1 Earnings Beat Estimates, Crop Science Unit Boosts SalesBAYRY beats Q1 earnings estimates as Crop Science sales rise, while Nubeqa and Kerendia gains help offset declines in Xarelto and Eylea.
